PrEP Implementation for Black Primary Care Patients
Brief description of study
The overarching goal of this proposal is to facilitate Dr. Watsons long-term goal to become an independent investigator focused on the development of implementation strategies to achieve equitable HIV prevention outcomes among Black populations. The results of this study will be important for the field of implementation science as it focuses on facilitating theory-informed behavior changes among providers and practice leadership to accelerate equitable PrEP provision for Black primary care patients. Findings from the pilot will inform the design and submission of an R01 application for a hybrid effectiveness-implementation trial of the implementation strategy in year 4. The proposal will form a strong foundation for Dr. Watsons continued development toward an independently funded research career as an implementation scientist invested in the development of implementation strategies to achieve equitable HIV prevention care outcomes among Black adults in the U.S. Our Project Objectives are as follows: 1. Identify key provider-, practice-, and community-level CFIR-based determinants of local PrEP delivery 2. Develop a theory-informed multifaceted implementation strategy that follows a destigmatizing sexual health framework to accelerate equitable PrEP delivery for adult Black primary care patients 3. Conduct a 12-month two-arm pilot trial to evaluate implementation strategy feasibility and acceptability at four medical practices that provide primary care services. Aim 3: The two primary outcomes for this non-blinded, non-randomized implementation 12-month pilot trial are acceptability and feasibility of the multifaceted implementation strategy: Acceptability of Intervention Measure (AIM) and Feasibility of Intervention Measure (FIM). Aim 3: The four secondary implementation outcomes will be measured at pilot month 6 and month 12 unless otherwise noted. (1) Multifaceted Implementation Strategy Appropriateness: A validated four-item appropriateness measure, Intervention Appropriateness Measure (IAM), will be used to measure the extent to which Staff found the strategy fit to support PrEP delivery (experimental arm only). (2) Multifaceted Implementation Strategy Adoption: The absolute number and percentage of Staff who completed at least 75% of pilot phase one activities (experimental arm only). (3) Innovation (PrEP) Adoption: The absolute number and percentage of Staff who prescribed PrEP in past 6 months per site and per study arm. (4) Innovation (PrEP) Equity: A composite metric of the absolute number and characteristics of PrEP clients; absolute number of initiation PrEP visits; and absolute number of return PrEP visits in the past 6 months per site and per study arm.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting